品牌货号 产品名称 | 阿拉丁rp184033 Recombinant Human Coagulation Factor Xa Protein |
---|---|
别名 | 重组人Coagulation Factor Xa蛋白 | 重组人凝血因子Xa蛋白 |
英文别名 | Cf10 | Coagulation Factor X | EC 3.4.21 | EC 3.4.21.6 | F10 | factor Xa | FX | FXa | Prothrombinase | Stuart Factor | Stuart-Prower factor |
规格或纯度 | 无动物源, 无载体, ≥95%(SDS-PAGE), 见COA |
生化机理 | Coagulation factor X, also known as FX, F10, Eponym Stuart-Prower factor, and thrombokinase, is an enzyme of the coagulation cascade. It is one of the vitamin K-dependent serine proteases, and plays a crucial role in the coagulation cascade and blood clotting, as the first enzyme in the common pathway of thrombus formation. Factor X deficiency is one of the rarest of the inherited coagulation disorders. FX deficiency among the most severe of the rare coagulation defects, typically including hemarthroses, hematomas, and umbilical cord, gastrointestinal, and central nervous system bleeding. Factor X is synthesized in the liver as a mature heterodimer formed from a single-chain precursor, and vitamin K is essential for its synthesis. Factor X is activated into factor Xa (FXa) by both factor IX (with its cofactor, factor VIII in a complex known as intrinsic Xase) and factor VII (with its cofactor, tissue factor in a complex known as extrinsic Xase) through cleaving the activation propeptide. As the first member of the final common pathway or thrombin pathway, FXa converts prothrombin to thrombin in the presence of factor Va, Ca2+, and phospholipid during blood clotting and cleaves prothrombin in two places (an arg-thr and then an arg-ile bond). This process is optimized when factor Xa is complexed with activated cofactor V in the prothrombinase complex. Inborn deficiency of factor X is very uncommon, and may present with epistaxis (nose bleeds), hemarthrosis (bleeding into joints) and gastrointestinal blood loss. Apart from congenital deficiency, low factor X levels may occur occasionally in a number of disease states. Furthermore, factor X deficiency may be seen in amyloidosis, where factor X is adsorbed to the amyloid fibrils in the vasculature. Post-translational: The vitamin K-dependent, enzymatic carboxylation of some glutamate residues allows the modified protein to bind calcium. The vitamin K-dependent, enzymatic carboxylation of some glutamate residues allows the modified protein to bind calcium. Proteolytically cleaved and activated by cathepsin CTSG. The activation peptide is cleaved by factor IXa (in the intrinsic pathway), or by factor VIIa (in the extrinsic pathway) (By similarity). The activation peptide is cleaved by factor IXa (in the intrinsic pathway), or by factor VIIa (in the extrinsic pathway) (By similarity). |
生物活性 | Testing in progress |
内毒素水平 | <1.0 EU/μg |
表达系统 | CHO |
种属 | 人(Human) |
氨基酸 | 1-488 aa |
序列 | MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLKHHHHHHHHHH |
蛋白标签 | C-10His |
无载体 | Yes |
无动物源 | Yes |
Accession # | P00742 |
来源 | 重组表达 |
预测分子量 | 52.7 kDa |
SDS-PAGE | 50.3 kDa, under reducing conditions; 69.4 kDa, under non-reducing conditions. |
公司名称:探究者科学器材(江苏)有限公司
全国客服热线:4006-765-543
地址:江苏省宿迁市经济技术开发区富民大道88号A12栋
邮编:223800
咨询/订货
关于探究者
售后服务
会员中心
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断、治疗或实验,不可药用,不可食用。
订购指南
Copyright © 2025 探究者科学器材(江苏)有限公司 All Rights Reserved 苏ICP备2025173400号-1